Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 20 Lymphoma 6 Urinary Bladder Neoplasms 3 Urothelial Carcinoma of the Bladder 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Choroid Plexus Neoplasms 1 Childhood Solid Tumor 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Astrocytoma 1

Interventions

Temozolomide 18 Magnetic Resonance Spectroscopy 15 Specimen Handling 13 Radiotherapy 13 Radiation 9 Biopsy 5 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 Nivolumab 4 Bevacizumab 4 vorasidenib 3 trametinib 3 Surgical Procedures, Operative 3 Spinal Puncture 3 tovorafenib 2 dabrafenib 2 Restraint, Physical 2 Leukapheresis 2 Ipilimumab 2 Genetic Therapy 2 Fluorodeoxyglucose F18 2 Eflornithine 2 Craniotomy 2 Carboplatin 2 14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene 2 vocimagene amiretrorepvec 1 veliparib 1 trastuzumab deruxtecan 1 tocilizumab 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Astrocytoma × Vinblastine × 1 year × Clear all

NCT05180825 2025-08-08

PLGG - MEKTRIC

University Hospital, Strasbourg, France

Phase 2 Recruiting

Astrocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡